Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)
Overview
Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy
Full Title of Study: “Evaluation of Retinal Structure With High Resolution OCT”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: November 27, 2023
Detailed Description
Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy
Interventions
- Other: Examination with an OCT device
Arms, Groups and Cohorts
- 1
- Healthy volunteers
- 2
- CSME secondary to diabetic retinopathy
- 3
- ARMD with CNV before and after therapy
- 4
- ARMD atrophic
- 5
- Retinal vein occlusion
- 6
- retinitis pigmentosa
- 7
- vitreoretinal proliferation
Clinical Trial Outcome Measures
Primary Measures
- Integrity of retinal layers
- Time Frame: End of study
Participating in This Clinical Trial
Inclusion Criteria
- Macular disease – Healthy subjects
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 100 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Sebastian Wolf
- Collaborator
- University of Bern
- Provider of Information About this Clinical Study
- Sponsor-Investigator: Sebastian Wolf, Director – Insel Gruppe AG, University Hospital Bern
- Overall Official(s)
- Sebastian Wolf, MD, PhD, Principal Investigator, University of Bern
- Sebastian Wolf, MD PhD, Study Director, University of Bern
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.